FILE - A sign marks an entrance to a Moderna building in Cambridge, Mass., on Monday, May 18, 2020. Shares of Merck and Moderna jumped early Tuesday, Dec. 13, 2022, after the drugmakers said a potential skin cancer vaccine they are developing using the same technology behind COVID-19 preventive shots did well in a mid-stage study.
The company said a possible melanoma vaccine it is studying with pharmaceutical giant Merck fared well in a small study of patients who had the cancer surgically removed. “We are very excited, we are moving very quickly with Merck onto phase 3 for this study,” Moderna CEO Stephane Bancel told CNBC Tuesday morning.
Caused by the Covid 19 vaccine*
DanielAndrewsMP great news for Victoria ? Guessing we will soon be manufacturing this cancer med.
A Cancer vax is how I am legend started.... Ya know just, FYI 🤷🏼♂️
How much myocarditis does it come with?
Just don't eat seed oils. Problem solved.
They’ve had problems with pesky side effects with their experimental “software of life” from the very beginning. So Operation Warp Speed was the best thing to ever happen to them…
noice
Fauci's son's own stocks in the vaccines (which didn't even work) and will soon be in jail.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Merck, Moderna detail potential skin cancer vaccine progressMerck and Moderna said a combination of the vaccine and Merck’s immunotherapy Keytruda led to a statistically significant improvement in recurrence-free survival time in patients with phase three or four melanoma who had the tumors removed in surgery.
Source: WBUR - 🏆 274. / 63 Read more »
Moderna and Merck team-up to fight melanomaVaccine-maker Moderna has partnered with the biopharmaceutical company Merck to create an effective treatment for skin cancer
Source: FoxBusiness - 🏆 458. / 53 Read more »
Merck, Moderna detail potential skin cancer vaccine progressThe drugmakers said a combination of the vaccine and Merck’s immunotherapy Keytruda led to a statistically significant improvement in recurrence-free survival time in patients with phase three or four melanoma who had tumors removed in surgery.
Source: wsfa12news - 🏆 338. / 59 Read more »
Merck, Moderna share positive progress of potential skin cancer vaccineA potential skin cancer vaccine being developed using the same technology behind COVID shots fared well in a small study, the drug companies said. FOX13 I bet they did. Now they want to give people cancer . Evil at its finest. God help their souls .
Source: fox13seattle - 🏆 328. / 59 Read more »
Positive Moderna, Merck cancer vaccine data advances mRNA promise, shares riseAn experimental cancer vaccine from Moderna based on the messenger RNA technology used in successful COVID vaccines has been shown to work against melanoma.
Source: Reuters - 🏆 2. / 97 Read more »
Merck, Moderna detail potential skin cancer vaccine progressThe drugmakers said a combination of the vaccine and Merck’s immunotherapy Keytruda led to a statistically significant improvement in recurrence-free survival time in patients with phase three or four melanoma who had tumors removed in surgery.
Source: WTVYNews4 - 🏆 590. / 51 Read more »